Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2).

Packer M, Carson P, Elkayam U, Konstam MA, Moe G, O'Connor C, Rouleau JL, Schocken D, Anderson SA, DeMets DL; PRAISE-2 Study Group.

JACC Heart Fail. 2013 Aug;1(4):308-14. doi: 10.1016/j.jchf.2013.04.004. Epub 2013 Aug 5.

PMID:
24621933
[PubMed - indexed for MEDLINE]
2.

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P; CORONA Study Group.

Eur Heart J. 2012 Sep;33(18):2290-6. Epub 2012 Apr 17.

PMID:
22513778
[PubMed - indexed for MEDLINE]
Free Article
3.

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators.

N Engl J Med. 2009 Nov 19;361(21):2019-32. doi: 10.1056/NEJMoa0907845. Epub 2009 Oct 30.

PMID:
19880844
[PubMed - indexed for MEDLINE]
Free Article
4.

Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data.

Gjesdal K, Feyzi J, Olsson SB.

Heart. 2008 Feb;94(2):191-6. Epub 2007 May 4.

PMID:
17483128
[PubMed - indexed for MEDLINE]
5.

Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW.

Arch Intern Med. 2007 Feb 12;167(3):239-45.

PMID:
17296878
[PubMed - indexed for MEDLINE]
6.

Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.

Gomberg-Maitland M, Wenger NK, Feyzi J, Lengyel M, Volgman AS, Petersen P, Frison L, Halperin JL.

Eur Heart J. 2006 Aug;27(16):1947-53. Epub 2006 Jun 14.

PMID:
16774980
[PubMed - indexed for MEDLINE]
Free Article
7.

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment.

Love RR, Wiebe DA, Feyzi JM, Newcomb PA, Chappell RJ.

J Natl Cancer Inst. 1994 Oct 19;86(20):1534-9.

PMID:
7932809
[PubMed - indexed for MEDLINE]
8.

Metastatic basal cell carcinoma. Report of five cases.

Snow SN, Sahl W, Lo JS, Mohs FE, Warner T, Dekkinga JA, Feyzi J.

Cancer. 1994 Jan 15;73(2):328-35.

PMID:
8293396
[PubMed - indexed for MEDLINE]
9.

Protein S and protein C level changes with adjuvant tamoxifen therapy in postmenopausal women.

Mamby CC, Love RR, Feyzi JM.

Breast Cancer Res Treat. 1994;30(3):311-4.

PMID:
7981450
[PubMed - indexed for MEDLINE]
10.

Tamoxifen-induced decreases in total cholesterol with 2 weeks of treatment.

Love RR, Mamby CC, Feyzi JM.

J Natl Cancer Inst. 1993 Aug 18;85(16):1344-5. No abstract available.

PMID:
8340948
[PubMed - indexed for MEDLINE]
11.

Reduction in vasomotor symptoms from tamoxifen over time.

Love RR, Feyzi JM.

J Natl Cancer Inst. 1993 Apr 21;85(8):673-4. No abstract available.

PMID:
8468727
[PubMed - indexed for MEDLINE]
12.

Oral piritrexim--a phase II study in patients with advanced soft tissue sarcoma.

Schiesel JD, Carabasi M, Magill G, Casper E, Cheng E, Marks L, Feyzi J, Clendeninn NJ, Smalley RV.

Invest New Drugs. 1992 Jul;10(2):97-8. No abstract available.

PMID:
1500271
[PubMed - indexed for MEDLINE]
13.

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women.

Love RR, Wiebe DA, Newcomb PA, Cameron L, Leventhal H, Jordan VC, Feyzi J, DeMets DL.

Ann Intern Med. 1991 Dec 1;115(11):860-4.

PMID:
1952472
[PubMed - indexed for MEDLINE]
14.

Plasma adrenocorticotropic hormone in the rat demonstrates three different rhythms within 24 h.

Carnes M, Lent S, Feyzi J, Hazel D.

Neuroendocrinology. 1989 Jul;50(1):17-25.

PMID:
2547174
[PubMed - indexed for MEDLINE]
15.

Risk factors for sensitization by blood transfusions. Comparison of the UW/Madison and UC/San Francisco donor-specific transfusion experience.

Burlingham WJ, Stratta R, Mason B, Lorentzen D, Feyzi J, Sollinger HW, Belzer FO.

Transplantation. 1989 Jan;47(1):140-4.

PMID:
2911870
[PubMed - indexed for MEDLINE]
16.

Immunoneutralization of corticotropin-releasing hormone prevents the diurnal surge of ACTH.

Carnes M, Lent SJ, Erisman S, Barksdale C, Feyzi J.

Life Sci. 1989;45(12):1049-56.

PMID:
2552244
[PubMed - indexed for MEDLINE]
17.

Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.

Girdley FM, Bruskewitz RC, Feyzi J, Graversen PH, Gasser TC.

J Urol. 1988 Nov;140(5):972-4.

PMID:
3172370
[PubMed - indexed for MEDLINE]
18.

Relating cerebral ischemia and hypoxia to insult intensity.

Emoto SE, Kintner D, Feyzi JM, Gilboe DD.

J Neurochem. 1988 Jun;50(6):1952-8.

PMID:
3373219
[PubMed - indexed for MEDLINE]
19.

Changes in mean plasma ACTH reflect changes in amplitude and frequency of secretory pulses.

Carnes M, Lent SJ, Erisman S, Feyzi J.

Life Sci. 1988;43(22):1785-90.

PMID:
2849007
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk